The company is a large national pharmaceutical retail chain enterprise (pharmacy chain listed on the Shanghai Main Board in China). It has focused on the pharmaceutical retail industry for 22 years, and has been ranked among the top 500 listed domestic pharmacy chains in terms of market capitalization. The company is mainly engaged in omni-channel chain retail business for products such as proprietary Chinese and Western medicines, Chinese medicine tablets, medical devices, health food, personal care products, and health-related convenience goods. The company's main products are retail chains such as proprietary Chinese and Western medicines, Chinese medicine tablets, medical devices, health foods, personal care products, and health-related convenience goods. Corporate honors: China's Listed Companies Golden Bull Award for Best Investment Value, 12th China Main Board Listed Companies Top 100, 2018 Hunan Top 100 Private Enterprises 28th, 11th China Main Board Listed Companies Top 100 Valuable Companies, etc. By the end of the reporting period, the total number of the company's stores was 14,736 (including 3,426 franchisees), a net increase of 1,486 compared with the end of the previous period. Achieved operating income of 11762.4011 million yuan, an increase of 9.86% over the previous year.
No Data
No Data